Cardiac Xenotransplantation: Current State and Future Directions.

Area of Science:

• Immunology
• Transplantation Biology
• Surgical Innovation

Background:

• Growing demand for donor hearts necessitates alternative solutions like xenotransplantation.
• Advances in genetic engineering and immunosuppression are key to overcoming xenograft rejection.
• Recent human trials with genetically modified pig hearts mark significant progress.

Purpose of the Study:

• To critically evaluate current advancements in cardiac xenotransplantation.
• To explore the ongoing challenges in the field of xenotransplantation.
• To discuss the future potential of xenotransplantation for addressing organ shortages.

Main Methods:

• Review of recent clinical cases involving genetically modified pig hearts in human recipients.
• Analysis of decedent studies monitoring xenograft function in brain-dead recipients.
• Examination of preclinical research in nonhuman primates for cardiac xenotransplantation.

Main Results:

• Two human patients received genetically modified pig hearts, surviving for 40 and 60 days respectively.
• Xenograft failure was observed in both human recipients prior to death.
• Decedent studies provide a novel paradigm for preclinical assessment of cardiac xenografts.

Conclusions:

• Significant progress has been made in overcoming hyperacute rejection in xenotransplantation.
• Adaptive cellular and humoral immunological barriers remain critical challenges.
• Xenotransplantation holds future potential for cardiac transplantation, pending further research and development.